Gene · 2864
Papers1,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120. | Front Immunol | 2022 | 36741381 | PubTator, text mining | PubMed |
| Gut microbiota and calcium balance. | Front Microbiol | 2022 | 36713159 | PubTator, text mining | PubMed |
| Genetic variation rs1121980 in the fat mass and obesity-associated gene (FTO) is associated with dietary intake in Koreans. | Food Nutr Res | 2022 | 36590860 | PubTator, text mining | PubMed |
| A review on the role of fatty acids in colorectal cancer progression. | Front Pharmacol | 2022 | 36578540 | PubTator, text mining | PubMed |
| Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration. | iScience | 2022 | 36561890 | PubTator, text mining | PubMed |
| Chemical Compounds and Ambient Factors Affecting Pancreatic Alpha-Cells Mass and Function: What Evidence? | Int J Environ Res Public Health | 2022 | 36554367 | PubTator, text mining | PubMed |
| FABP4 in Paneth cells regulates antimicrobial protein expression to reprogram gut microbiota. | Gut Microbes | 2022 | 36519446 | PubTator, text mining | PubMed |
| Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action. | ACS Med Chem Lett | 2022 | 36518697 | PubTator, text mining | PubMed |
| Fish Oil and Selenium with Doxorubicin Modulates Expression of Fatty Acid Receptors and Selenoproteins, and Targets Multiple Anti-Cancer Signaling in Triple-negative Breast Cancer Tumors. | Int J Med Sci | 2022 | 36483592 | PubTator, text mining | PubMed |
| A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates. | Front Endocrinol (Lausanne) | 2022 | 36482991 | PubTator, text mining | PubMed |
| Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis. | Front Neurol | 2022 | 36438957 | PubTator, text mining | PubMed |
| Genetic variants in taste genes play a role in oral microbial composition and severe early childhood caries. | iScience | 2022 | 36404915 | PubTator, text mining | PubMed |
| Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders. | Front Pharmacol | 2022 | 36386134 | PubTator, text mining | PubMed |
| The Impact of Dietary Fat on Breast Cancer Incidence and Survival: A Systematic Review. | Cureus | 2022 | 36381753 | PubTator, text mining | PubMed |
| Dihydromyricetin Enhances Exercise-Induced GLP-1 Elevation through Stimulating cAMP and Inhibiting DPP-4. | Nutrients | 2022 | 36364846 | PubTator, text mining | PubMed |
| The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity. | Int J Mol Sci | 2022 | 36362376 | PubTator, text mining | PubMed |
| Differential Expression of lncRNA-miRNA-mRNA and Their Related Functional Networks in New-Onset Type 2 Diabetes Mellitus among Chinese Rural Adults. | Genes (Basel) | 2022 | 36360309 | PubTator, text mining | PubMed |
| The Expression Patterns of Human Cancer-Testis Genes Are Induced through Epigenetic Drugs in Colon Cancer Cells. | Pharmaceuticals (Basel) | 2022 | 36355490 | PubTator, text mining | PubMed |
| Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence. | Pharmaceuticals (Basel) | 2022 | 36355476 | PubTator, text mining | PubMed |
| CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. | Cancer Cell Int | 2022 | 36344976 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2864/papers?page=13